tirzepatide side effects vs semaglutide side effects vs. for Weight Loss: Which Is Right for Me? Semaglutide vs Tirzepatide: Effectiveness, Side

Understanding these genetic factors can support a more informed conversation with your provider about whether GLP-1 therapy aligns with your metabolic profile

Inhaled GLP-1 formulations

Living Longer by Living Better Longevity has always depended on how the heart, mind, and metabolism work together

While originally developed for glucose control, GLP-1 receptor agonists may also help lower uric acid levels and reduce the likelihood of gout

Found is appropriate for patients with obesity (BMI 30) or overweight with comorbidities (diabetes, hypertension), those meeting GLP-1 clinical criteria, and individuals who have not responded adequately to behavioral interventions alone

Lillys orforglipron (Foundayo), FDA-approved April 2026, is oral but not tirzepatide: 11.2% loss at 72 weeks, no food or water restrictions